Science Explorer Interactive view Map
Company · Redwood City · United States

Soleno Therapeutics (United States)

soleno.lifeROR OpenAlex
Research works
17
fractional, all time
Citations
86
5.2 per fractional work
Top-10% rate
11.4%
record average 16.5%
Open access
59%
world 28%

Not ranked overall: Soleno Therapeutics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.70× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 5.12× its world share, 3 worksBiochemistry, Geneti…Immunology and Microbiology: 6.51× its world share, 1 worksImmunology and Micro…Neuroscience: 1.13× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 2.13× its world share, 0 worksPharmacology, Toxico…Energy: 0.36× its world share, 0 worksEnergyEnvironmental Science: 0.30× its world share, 0 worksEnvironmental ScienceHealth Professions: 3.42× its world share, 1 worksHealth ProfessionsMedicine: 2.56× its world share, 5 worksMedicinePsychology: 0.07× its world share, 0 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 6.5×. Every wedge is a field page.

Which research topics does Soleno Therapeutics (United States) publish most on?

By volume in 2022–2025: Genetic Syndromes and Imprinting, Adolescent and Pediatric Healthcare, HER2/EGFR in Cancer Research and Monoclonal and Polyclonal Antibodies Research.

Genetic Syndromes and Imprinting: 1 fractional worksAdolescent and Pediatric Healthcare: 1 fractional worksHER2/EGFR in Cancer Research: 1 fractional worksMonoclonal and Polyclonal Antibodies Research: 1 fractional worksCell Adhesion Molecules Research: 0 fractional worksMast cells and histamine0Mast cells and histamine: 0 fractional worksMyeloproliferative Neoplasms: Diagnosis and Treatment: 0 fractional worksChronic Myeloid Leukemia Treatments: 0 fractional worksGenomic variations and chromosomal abnormalities: 0 fractional worksCancer Treatment and Pharmacology: 0 fractional works
GeneticsSpeech and HearingOncologyRadiology, Nuclear Medicine and Imaging3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Genetic Syndromes and Imprinting Genetics 1 works
  2. 2 Adolescent and Pediatric Healthcare Speech and Hearing 1 works
  3. 3 HER2/EGFR in Cancer Research Oncology 1 works
  4. 4 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  5. 5 Cell Adhesion Molecules Research Immunology and Allergy 0 works
  6. 6 Mast cells and histamine Immunology 0 works
  7. 7 Myeloproliferative Neoplasms: Diagnosis and Treatment Genetics 0 works
  8. 8 Chronic Myeloid Leukemia Treatments Hematology 0 works
  9. 9 Genomic variations and chromosomal abnormalities Genetics 0 works
  10. 10 Cancer Treatment and Pharmacology Oncology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available59.3%not open40.7%

World: 28% of research is openly available.

with international co-authors30.5%domestic only69.5%

World: 19% is written across borders.

How has Soleno Therapeutics (United States)'s research output changed?

2005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Redwood City

All research institutions in Redwood City

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.